The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?

被引:194
作者
Melander, Roberta J. [1 ]
Melander, Christian [1 ]
机构
[1] North Carolina State Univ, Dept Chem, 2620 Yarbrough Dr, Raleigh, NC 27695 USA
基金
美国国家卫生研究院;
关键词
BETA-LACTAMASE INHIBITORS; STAPHYLOCOCCUS-AUREUS; COMBINATION THERAPY; EFFLUX PUMPS; BAD BUGS; STRATEGIES; DRUGS; POTENTIATION; INFECTIONS; MECHANISMS;
D O I
10.1021/acsinfecdis.7b00071
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Antibiotic resistance is one of the greatest current threats to human health, and without significant action we face the chilling prospect of a world without effective antibiotics. Although continued effort toward the development of new antibiotics, particularly those with novel mechanisms of action, remains crucial, this alone probably will not be enough to prevail, and it is imperative that additional approaches are also explored. One such approach is the identification of adjuvants that augment the activity of current antibiotics. This approach has the potential to render an antibiotic against which bacteria have developed resistance once again effective, to broaden the spectrum of an antibiotic, and to lower the required dose of an antibiotic. In this viewpoint we discuss some of the advantages and disadvantages of the use of adjuvants, and describe various approaches to their identification.
引用
收藏
页码:559 / 563
页数:5
相关论文
共 53 条
[1]   RecA Inhibitors Potentiate Antibiotic Activity and Block Evolution of Antibiotic Resistance [J].
Alam, Md Kausar ;
Alhhazmi, Areej ;
DeCoteau, John F. ;
Luo, Yu ;
Geyer, C. Ronald .
CELL CHEMICAL BIOLOGY, 2016, 23 (03) :381-391
[2]   Importance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosa [J].
Alipour, Misagh ;
Suntres, Zacharias E. ;
Omri, Abdelwahab .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 64 (02) :317-325
[3]  
[Anonymous], 2014, Antimicrobial Resistance: Tackling a crisis forthe health and wealth of nations
[4]   Antibiotics: the changing regulatory and pharmaceutical industry paradigm [J].
Bax, Richard ;
Green, Samantha .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (05) :1281-1284
[5]   Molecular mechanisms of antibiotic resistance [J].
Blair, Jessica M. A. ;
Webber, Mark A. ;
Baylay, Alison J. ;
Ogbolu, David O. ;
Piddock, Laura J. V. .
NATURE REVIEWS MICROBIOLOGY, 2015, 13 (01) :42-51
[6]   Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].
Boucher, Helen W. ;
Talbot, George H. ;
Bradley, John S. ;
Edwards, John E., Jr. ;
Gilbert, David ;
Rice, Louis B. ;
Scheld, Michael ;
Spellberg, Brad ;
Bartlett, John .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12
[7]   Phosphorylation of BlaR1 in Manifestation of Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus and Its Abrogation by Small Molecules [J].
Boudreau, Marc A. ;
Fishovitz, Jennifer ;
Llarrull, Leticia I. ;
Xiao, Qiaobin ;
Mobashery, Shahriar .
ACS INFECTIOUS DISEASES, 2015, 1 (10) :454-459
[8]   The Quorum Sensing Inhibitor Hamamelitannin Increases Antibiotic Susceptibility of Staphylococcus aureus Biofilms by Affecting Peptidoglycan Biosynthesis and eDNA Release [J].
Brackman, Gilles ;
Breyne, Koen ;
De Rycke, Riet ;
Vermote, Arno ;
Van Nieuwerburgh, Filip ;
Meyer, Evelyne ;
Van Calenbergh, Serge ;
Coenye, Tom .
SCIENTIFIC REPORTS, 2016, 6
[9]   Antibacterial drug discovery in the resistance era [J].
Brown, Eric D. ;
Wright, Gerard D. .
NATURE, 2016, 529 (7586) :336-343